Skip to main content

Table 1 Patient characteristics across study cohorts

From: Preventive treatment patterns in the adult migraine population: an observational UK study over 7 years

 

CPRD Migraine Cohort (N = 81,190)

CPRD Migraine Preventive Treatment User Cohort (N = 34,448)

CPRD Migraine Preventive Treatment User Cohort with ≥ 3 oral migraine preventive medication class cessations* (N = 2653)

Mean age (years, SD)

42.5 (15.5)

45.8 (15.7)

45.0 (14.6)

 18–65 years

 > 65 years

74,051 (91.2)

7139 (8.8)

30,443 (88.4)

4005 (11.6)

2410 (90.8)

243 (9.2)

Gender – female (n, %)

62,754 (77.3)

27,226 (79.0)

2200 (82.9)

History of referral to neurologist (n, %)

5715 (7.0)

3801 (11.0)

576 (21.7)

  1. CPRD: Clinical Practice Research Datalink; N: number of patients in total population; n: number of patients in group
  2. *Medication class was considered ceased when no evidence of restart of the same medication class within 6 months from end-of-supply date during the medication assessment period